Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Growth factor-mediated tissue regeneration leverages key protein signals delivered locally via advanced biomaterials or engineered constructs to orchestrate complex cellular events required for effective tissue repair across multiple organ systems. Key growth factor families involved include FGFs, BMPs, VEGF, PDGFs, and the TGF‐β family, which act by binding to receptor tyrosine kinases and activating intracellular signaling pathways. Effective delivery strategies are crucial, including direct injection, scaffold incorporation, and fusion protein engineering. Applications span bone, muscle, tendon, cartilage, nerve, and skin regeneration. Challenges remain regarding safety, dosing, delivery, and regulatory approval.
Activation of intracellular pathways driving proliferation, migration, and differentiation through growth factor receptors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth Factor-Mediated Tissue Regeneration.